Compare IMVT & MSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | MSM |
|---|---|---|
| Founded | 2018 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.0B |
| IPO Year | 2019 | 1996 |
| Metric | IMVT | MSM |
|---|---|---|
| Price | $33.39 | $107.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | $33.00 | ★ $96.20 |
| AVG Volume (30 Days) | ★ 2.3M | 600.8K |
| Earning Date | 05-28-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $3,363,817,000.00 |
| Revenue This Year | N/A | $5.82 |
| Revenue Next Year | N/A | $5.26 |
| P/E Ratio | ★ N/A | $64.29 |
| Revenue Growth | N/A | ★ 4.99 |
| 52 Week Low | $14.09 | $78.80 |
| 52 Week High | $36.29 | $108.85 |
| Indicator | IMVT | MSM |
|---|---|---|
| Relative Strength Index (RSI) | 63.49 | 62.30 |
| Support Level | $22.84 | $82.74 |
| Resistance Level | N/A | $108.77 |
| Average True Range (ATR) | 1.94 | 2.76 |
| MACD | 0.54 | -0.13 |
| Stochastic Oscillator | 72.62 | 72.18 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.